AI assistant
Sending…
MODINE MANUFACTURING CO — Director's Dealing 2013
Jul 19, 2013
30783_dirs_2013-07-19_bde77d78-89ef-42fb-b3db-65bf6bebe361.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MODINE MANUFACTURING CO (MOD)
CIK: 0000067347
Period of Report: 2013-07-18
Reporting Person: McBurney Matthew J (VP, Commercial Products Group)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 15665 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option (right to buy) | $27.22 | 2017-01-16 | Common stock (600) | Direct | |
| Employee stock option (right to buy) | $13.33 | 2018-02-11 | Common stock (1000) | Direct | |
| Employee stock option (right to buy) | $9.26 | 2020-06-11 | Common stock (2522) | Direct | |
| Employee stock option (right to buy) | $14.93 | 2021-07-21 | Common stock (1583) | Direct | |
| Employee stock option (right to buy) | $5.75 | 2022-06-05 | Common stock (5519) | Direct | |
| Employee stock option (right to buy) | $10.40 | 2023-06-03 | Common stock (3523) | Direct |
Footnotes
F1: Includes 320 units owned through the Modine 401(k) Retirement Plan. Each unit consists of Modine common stock and cash components.
F2: This option vests in four equal annual increments commencing on the date of grant (6/11/10).
F3: This option vests in four equal annual increments commencing on the date of grant (7/21/11).
F4: This option vests in four equal annual increments commencing on the date of grant (6/5/12).
F5: This option will vest in four equal annual increments commencing on 6/3/14.
More from MODINE MANUFACTURING CO
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 18
Regulatory Filings
2026
Feb 17
Interim / Quarterly Report
2026
Feb 5
Regulatory Filings
2026
Feb 4
Director's Dealing
2026
Feb 3